Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





2025 ADLM Data Science Symposium to Connect Data Scientists with Clinical Professionals

By LabMedica International staff writers
Posted on 28 Jul 2025

For the second year in a row, the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA) has added a Data Science Symposium to its meeting program. More...

This free event will start at 1 p.m. on July 31, the last day of ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo).

The 2024 ADLM Data Science Symposium featured a variety of panel discussions and project talks on topics essential to artificial intelligence (AI) and machine learning in the clinical laboratory, and the 2025 symposium promises more of the same. ADLM's Data Analytics Steering Committee wants to build on the success of last year’s symposium, which exceeded their expectations, and has created a full and varied agenda. The event is important to ADLM’s mission to serve as a place where data scientists and laboratory medicine can find a home. Although there is no cost for the symposium, people who would like to attend must register in advance. The symposium provides an opportunity for the attendees to come together and specifically talk about data science rather than the mixed topics from the annual meeting. The day will be packed with impactful “lightning” talks, where experts talk for 10 to 15 minutes about their current work in data science. For example, Hunter Miller, PhD, clinical chemistry fellow at the University of Louisville, will speak about using artificial intelligence (AI) to aid in the interpretation of serum protein immunofixation electrophoresis.

In addition, Nick Spies, MD, medical director of applied AI at ARUP, will discuss how IV fluid contamination in CBCs can lead to unnecessary RBC transfusions. Keeping lightning talks short helps ensure that each one packs a punch — and a variety of topics can be covered. The symposium will also include two panel presentations. The first one, called “Is AI ‘Snake Oil’?” features He Sarina Yang, PhD, DABCC, associate professor in pathology at Weill Cornell Medicine; Bobby Reddy Jr., PhD, CEO, and co-founder of Prenosis; and Mark Zaydman, MD, PhD, assistant professor of pathology and immunology at Washington University in St. Louis. The second panel will be about leveraging data science to quantify the value of laboratory medicine testing. It features Daniel Herman, MD, PhD, assistant professor of pathology and laboratory medicine at the University of Pennsylvania; Lee Schroeder, MD, PhD, director of point-of-care testing at the University of Michigan, and two additional panelists who are yet to be determined.

The symposium brings together a lot of different perspectives on data science for all of the laboratories, not just one specific kind of laboratory, with participants coming from academia, community hospitals, and industry. Sarah Wheeler, PhD, FADLM, CC(NRCC), chair of ADLM’s Data Analytics Steering Committee and associate professor of pathology at the University of Pittsburgh, hopes the summit will connect data scientists with clinical professionals, industry colleagues, and “people who are interested in adding data science to their repertoire as laboratory medicine professionals but haven’t necessarily stepped into that yet,” she said. “This is a really great forum for us all to be communicating because cross-disciplinary dialogue is vital to moving laboratory medicine data science forward to help our patients.”

Related Links:
ADLM


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Tracking blood test trends alongside unexplained weight loss may help identify patients at increased cancer risk and support earlier investigation (Image Credit: 123RF)

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care

Unexplained weight loss is a common but nonspecific presentation in primary care that can precede several types of cancer, making referral decisions difficult. Routine blood tests may produce borderline... Read more

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.